a.petrov
TL2 Moderator · Dhaka
Contributes reviews on supplier material. Based in Dhaka.
Joined 22 December 2024 · last posted 4d
78 posts, newest first. Showing up to 150.
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #64 · Practice › Interactions · 24 Jul 2026 · 28 likes This follows post #61 rather than contradicting it. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #95 · Analytics › Home & field testing · 17 Jul 2026 · 3 likes post #94 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
How shortages have affected compounding permissions Replied, post #45 · Access › Shortages · 17 Jul 2026 · 9 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #76 · Analytics › Home & field testing · 12 Jul 2026 · 4 likes Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative…
-
Tirzepatide storage and stability: what is published versus what is assumed Started this topic · Compounds › Tirzepatide · 9 Jul 2026 · 1 like On the subject in the title: Tirzepatide storage and stability: what is published versus what is assumed Working notes rather than a conclusion. Session topic:…
-
Documenting a supplier's response to a discrepancy Replied, post #21 · Sourcing › Vendor reports · 23 Jun 2026 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Prescription portability between countries Replied, post #69 · Access › International · 19 Jun 2026 · 21 likes I read post #67 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #21 · Start Here › Welcome · 17 Jun 2026 · 4 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #31 · Compounds › Secretagogues & GH axis · 11 Jun 2026 · 0 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #20 · Compounds › Tirzepatide · 6 Jun 2026 · 27 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #77 · Sourcing › Red flags · 6 Jun 2026 · 16 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
-
What I would want from a home test that does not exist yet Started this topic · Analytics › Home & field testing · 29 May 2026 · 7 likes The question in the title: What I would want from a home test that does not exist yet I will give what I have already checked below so nobody repeats it. A…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #37 · Start Here › Welcome · 27 May 2026 · 0 likes I read post #35 twice before replying, because I had assumed the opposite. The moderation log is public. Every staff action is logged with the rule cited and the…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #36 · Clinical › Bloodwork · 25 May 2026 · 15 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
Reading a trial's population section before its results Replied, post #48 · Evidence › Trials · 24 May 2026 · 9 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Blind submission and why it changes minds — the long version Replied, post #70 · Sourcing › Independent verification · 11 May 2026 · 26 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
Why the timeline is on the right and not the left — what changed since Replied, post #32 · Meta › Site feedback · 7 May 2026 · 6 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #33 · Practice › Reconstitution · 3 May 2026 · 0 likes post #32 is right about the mechanism and I think understates the practical bit. Foaming during reconstitution: bubbles in the solution are usually just air…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #13 · Practice › Storage & stability · 2 May 2026 · 10 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Request: show the solution author in the topic list — what changed since Replied, post #8 · Meta › Feature requests · 30 Apr 2026 · 31 likes Tracking: staff will update the status of feature requests (under consideration, planned, implemented, declined). Checking back lets you know the fate of your suggestion.
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #10 · Compounds › Tirzepatide · 30 Apr 2026 · 0 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Journal club: is percentage weight change the right endpoint? Replied, post #29 · Evidence › Journal club · 1 Apr 2026 · 14 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Grapefruit: why this class is not the class that cares Replied, post #57 · Practice › Interactions · 19 Mar 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #92 · Wellbeing › Mental health · 16 Feb 2026 · 3 likes Worth separating two things that post #88 runs together. Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #42 · Start Here › Welcome · 14 Feb 2026 · 14 likes This follows post #39 rather than contradicting it. Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters…
-
Trifluoroacetate content and its consequences Replied, post #94 · Analytics › Impurities & related substances · 6 Feb 2026 · 5 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #8 · Practice › Side effects · 31 Dec 2025 · 0 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #40 · Data & Tools › Calculators · 15 Dec 2025 · 5 likes I read post #38 twice before replying, because I had assumed the opposite. Why calculators are not medical advice: they do arithmetic. Medical decisions are not…
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #24 · Compounds › Retatrutide · 13 Dec 2025 · 4 likes What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #3 · Practice › Administration · 5 Dec 2025 · 0 likes Worth separating two things that the opening post runs together. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #104 · Sourcing › Vendor reports · 5 Dec 2025 · 2 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #19 · Compounds › Tirzepatide · 2 Dec 2025 · 5 likes Worth separating two things that post #15 runs together. Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly…
-
Tracking that stops updating and then resumes Replied, post #47 · Sourcing › Logistics · 18 Nov 2025 · 11 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
[2026 update] Splitting an overlong document into two Replied, post #48 · Documentation › Wiki requests · 7 Nov 2025 · 1 like Correction requests: if you spot an error in a maintained page, note it here with the specific correction. The maintainer will review and update if justified.
-
New subcategory: rationale and scope Replied, post #110 · Meta › Announcements · 24 Oct 2025 · 26 likes Picking up post #107: that is the part I would want checked first. When announcements are made: major policy changes, technical changes affecting site function, planned…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #82 · Devices › Cold chain · 27 Sep 2025 · 7 likes Picking up post #79: that is the part I would want checked first. Shipping container and cold packs: reputable suppliers use insulated containers with cold packs…
-
Which panel is worth repeating and which is worth ignoring Replied, post #115 · Clinical › Bloodwork · 19 Sep 2025 · 5 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Gauge and length selection for subcutaneous injection Replied, post #28 · Devices › Syringes & needles · 9 Sep 2025 · 10 likes This follows post #25 rather than contradicting it. Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer).…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #66 · Data & Tools › Datasets · 9 Sep 2025 · 0 likes This follows post #63 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #116 · Compounds › Tirzepatide · 31 Aug 2025 · 3 likes post #115 answers the question as asked. The question underneath it is different. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long.…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #16 · Compounds › Tirzepatide · 26 Aug 2025 · 1 like Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #31 · Evidence › Journal club · 14 Aug 2025 · 12 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #17 · Analytics › COA interpretation · 8 Aug 2025 · 19 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #38 · Practice › Reconstitution · 8 Aug 2025 · 4 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
How to research a compound with no human data without deceiving yourself Replied, post #48 · Compounds › Other compounds · 1 Aug 2025 · 20 likes On post #44 — agreed on the reasoning, with one qualification. Compounds this community declines to help with, and why: there are specifics in the guidelines and they…
-
Asking about a compound your prescriber has not heard of Replied, post #103 · Clinical › Prescriber conversations · 23 Jul 2025 · 0 likes Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit after a defined time, or other reasons? Knowing in advance is…
-
Comparing my trajectory with the trial curves, carefully Replied, post #27 · Outcomes › Progress reports · 22 Jul 2025 · 10 likes Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording them anyway creates a record you can look back on.
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #72 · Compounds › Repair & healing peptides · 17 Jul 2025 · 8 likes I read post #70 twice before replying, because I had assumed the opposite. Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible…
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #38 · Compounds › Cagrilintide & amylin analogues · 8 Jul 2025 · 0 likes I read post #36 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #9 · Practice › Dosing & titration · 7 Jul 2025 · 23 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
Repeatability versus intermediate precision Replied, post #102 · Analytics › Method validation · 30 Jun 2025 · 2 likes Coming back to post #100, because the follow-up matters more than the original answer. Transfer between laboratories: a method can be transferred from one lab to…
-
Pre-registering a personal experiment, seriously Replied, post #86 · Research Methods › N-of-1 designs · 2 Jun 2025 · 10 likes Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An experiment designed so that any result confirms what…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #5 · Documentation › Doc review · 24 May 2025 · 17 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.
-
Pregnancy as an absolute contraindication Replied, post #44 · Safety › Contraindications · 18 May 2025 · 0 likes This follows post #41 rather than contradicting it. Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential benefits. Planning…
-
Pen wastage and its effect on real cost — the long version Replied, post #2 · Access › Pricing · 17 May 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A supplier that answers analytical questions with restated claims Replied, post #72 · Sourcing › Red flags · 8 May 2025 · 16 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
Antibiotics and a course of something with delayed emptying Replied, post #27 · Practice › Interactions · 24 Apr 2025 · 0 likes Worth separating two things that post #23 runs together. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining…
-
Requesting a page: what makes a good request Replied, post #41 · Documentation › Wiki requests · 1 Apr 2025 · 10 likes I read post #39 twice before replying, because I had assumed the opposite. Request a new maintained page: if a question recurs, has a good marked solution, and contains…
-
Checking someone else's arithmetic: a worked example thread Replied, post #32 · Practice › Reconstitution · 24 Mar 2025 · 15 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #118 · Access › International · 23 Mar 2025 · 9 likes On post #114 — agreed on the reasoning, with one qualification. Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers.…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #60 · Practice › Reconstitution · 22 Mar 2025 · 6 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Maintainer handover: how it works Replied, post #22 · Meta › Wiki maintenance · 14 Mar 2025 · 32 likes Worth separating two things that post #18 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #101 · Sourcing › Regulatory · 4 Mar 2025 · 2 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #27 · Compounds › Semaglutide · 3 Mar 2025 · 0 likes Picking up post #24: that is the part I would want checked first. On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and…
-
Distinguishing a deletion sequence by mass alone Replied, post #130 · Analytics › Mass spectrometry · 24 Feb 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: How to tell whether your question is already answered on a maintained page Started this topic · Start Here › Welcome · 7 Feb 2025 · 20 likes How to tell whether your question is already answered on a maintained page I have a specific reason for asking rather than idle curiosity, and the context is below.…
-
Protein density versus volume when you cannot eat much Replied, post #51 · Nutrition & Training › Protein & intake · 1 Feb 2025 · 22 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
-
Isotonicity and what happens when you get it wrong Replied, post #32 · Pharmacology › Formulation chemistry · 18 Jan 2025 · 11 likes Picking up post #29: that is the part I would want checked first. Amino acid residues and formulation: the specific sequence and composition of a peptide affects what…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #47 · Compounds › Cagrilintide & amylin analogues · 8 Jan 2025 · 1 like I read post #45 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
The topic list is dense — is that deliberate? Replied, post #79 · Meta › Site feedback · 8 Jan 2025 · 2 likes Worth separating two things that post #75 runs together. Bugs and friction: the parts of the site that do not work the way you expected. Report them specifically (what…
-
Coming back to: When to suspect the method rather than the sample Replied, post #114 · Analytics › Method validation · 22 Dec 2024 · 0 likes post #113 answers the question as asked. The question underneath it is different. System suitability: injections run at the start of a batch to establish that the…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #7 · Pharmacology › Receptor biology · 18 Dec 2024 · 25 likes Worth separating two things that post #3 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #99 · Compounds › Repair & healing peptides · 20 Nov 2024 · 15 likes Worth separating two things that post #95 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Gallbladder disease risk with rapid weight loss Replied, post #24 · Clinical › Comorbidities · 28 Oct 2024 · 7 likes On post #20 — agreed on the reasoning, with one qualification. Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #6 · Evidence › Journal club · 24 Oct 2024 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Blind submission and why it changes minds Replied, post #38 · Sourcing › Independent verification · 17 Aug 2024 · 7 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Reimbursement variation across member states Started this topic · Regional › European Union · 12 Aug 2024 · 0 likes On the subject in the title: Second pass at: Reimbursement variation across member states Working notes rather than a conclusion. A coverage question with the paperwork…
-
Guidelines revision: what changed and why Replied, post #99 · Meta › Announcements · 28 Jul 2024 · 1 like RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for this subcategory.